Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PAVmed Inc. (PAVM)
USD6.01
+0.34 (+6.00%)
US NASDAQ Healthcare Medical - Devices
Address
One Grand Central Place 10165
New York City, NY, US
New York City, NY, US
CEO
Lishan Aklog
Website
pavmed.com
IPO
2016-07-27
CIK 1624326 ISIN US70387R5028
Also trades on
NASDAQ Capital Market · PAVM (USD)
NASDAQ Capital Market · PAVMW (USD)
NASDAQ Capital Market · PAVMZ (USD)
Description
PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and EsoGuard, a specialized bisulfite-converted next-generation sequencing DNA assay. The company's extensive development pipeline further encompasses EsoCure, an esophageal ablation device intended to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; and NextFlo, a disposable infusion platform technology. Also in development are the Veris cancer healthcare platform, which features an intelligent vascular port for combined remote monitoring and data analytics, alongside Veris cardiac monitors. Additional innovations include NextVent single-use ventilators, FlexMO medical circulatory support cannulas, DisappEAR resorbable pediatric ear tubes, and Solys for noninvasive glucose monitoring. Established in 2014, the enterprise originally traded as PAXmed Inc. before rebranding to PAVmed Inc. in April 2015. Its corporate headquarters are located in New York, New York.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD6.01
+0.34 (+6.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
17.5K
Beta
0.56
Float Shares
441.2K
Free Float %
82.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.25% | -8.76% | -22.48% | -50.98% | -49.49% | -24.47% | -73.35% | -97.17% | -99.81% | -99.78% | -99.78% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (3 ratings, all time)
Buy
Price Targets & DCF
Current price
6.01
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-9.41
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%-97.6% Q1'26: +175.0% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-137.8% Q1'26: -143.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-3,235.2% Q1'26: -11,909,090.9% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-3,447.9% Q1'26: -4,822.7% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-7.2% Q1'26: -11.9% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%-69.2% ★ Q1'26: -9.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-5.70× Q1'26: -4.09× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 2.00M (-100.0%)
|
—
est: 144.0K (-100.0%)
|
500.0K
est: 662.5K (-24.5%)
|
377.0K
est: 541.3K (-30.3%)
|
2.45M
est: 3.83M (-36.0%)
|
3.00M
est: 3.01M (-0.6%)
|
71.0K
est: 44.5K (+59.6%)
|
340.0K
290.1K – 389.9K
+664.0% YoY
|
652.5K
556.7K – 748.3K
+91.9% YoY
|
| EBITDA |
-12.07M
est: -400.0K (-2,917.8%)
|
-16.67M
est: -28.8K (-57,787.4%)
|
-55.90M
est: -132.5K (-42,089.0%)
|
-99.50M
est: -108.2K (-91,817.7%)
|
-75.74M
est: -2.30M (-3,196.9%)
|
29.67M
est: -1.81M (+1,741.5%)
|
-2.34M
est: -26.7K (-8,675.3%)
|
-204.0K
-233.9K – -174.1K
-664.0% YoY
|
-391.5K
-449.0K – -334.0K
-91.9% YoY
|
| EBIT |
-15.17M
est: -400.0K (-3,691.4%)
|
-16.69M
est: -28.8K (-57,836.8%)
|
-56.13M
est: -132.5K (-42,259.6%)
|
-101.96M
est: -108.2K (-94,087.5%)
|
-78.67M
est: -2.30M (-3,324.5%)
|
28.47M
est: -1.81M (+1,675.2%)
|
-2.45M
est: -26.7K (-9,068.5%)
|
-204.0K
-233.9K – -174.1K
-664.0% YoY
|
-391.5K
-449.0K – -334.0K
-91.9% YoY
|
| Net Income |
-17.97M
est: -590.90M (+97.0%)
|
-15.93M
est: -405.19M (+96.1%)
|
-50.35M
est: -483.98M (+89.6%)
|
-88.98M
est: -875.10M (+89.8%)
|
-64.18M
est: -5.42M (-1,084.6%)
|
39.79M
est: 50.29M (-20.9%)
|
401.0K
est: -2.41M (+116.6%)
|
-2.11M
-2.51M – -1.70M
+12.8% YoY
|
-858.2K
-1.02M – -694.4K
+59.2% YoY
|
| SGA |
6.31M
est: 105.15M (-94.0%)
|
7.66M
est: 7.57M (+1.2%)
|
34.32M
est: 34.83M (-1.5%)
|
60.73M
est: 28.46M (+113.4%)
|
48.53M
est: 185.36B (-100.0%)
|
36.15M
est: 145.84B (-100.0%)
|
17.17B
est: 2.15B (+696.9%)
|
16.46B
14.04B – 18.88B
+664.0% YoY
|
31.59B
26.95B – 36.22B
+91.9% YoY
|
| EPS |
-378.78
est: -9.05 (-4,085.4%)
|
-249.27
est: -6.21 (-3,916.7%)
|
-293.92
est: -7.41 (-3,865.2%)
|
-450.95
est: -13.40 (-3,264.6%)
|
-274.92
est: -8.08 (-3,302.5%)
|
99.15
est: 75.00 (+32.2%)
|
-5.63
est: -3.60 (-56.4%)
|
-3.14
-3.74 – -2.54
+12.8% YoY
|
-1.28
-1.52 – -1.04
+59.2% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-06-08 | Ascendiant Capital | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-03 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-02 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-13 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 3/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-05 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-01 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-2.63B
OE per share TTM
-1,670.86
Owner's Yield
-35,536.40%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
280.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
27
Total invested
426.5K
Insider transactions (90d)
0
Beneficial owners (>5%)
27
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PAVmed, Inc. | 27.93M | 75.50% | 27.93M | — | 27.93M | — | CO | — | 2021-10-27 | ↗ |
| 2 | BARCLAYS GLOBAL INVESTORS, NA. | 10.57M | 4.75% | — | 950.0K | — | 950.0K | BK | Cayman Islands | 2018-06-26 | ↗ |
| 3 | Aklog | 9.23M | 42.60% | 6.38M | 2.85M | 6.38M | 2.85M | IN | States | 2018-04-26 | ↗ |
| 4 | Lishan Aklog | 8.47M | 63.60% | 2.52M | 5.95M | 2.52M | 5.95M | IN | United States | 2016-05-13 | ↗ |
| 5 | Ira Scott Greenspan | 7.77M | 33.90% | 1.24M | 6.53M | 1.24M | 6.53M | IN | United States | 2018-02-28 | ↗ |
| 6 | HCFP/Capital Partners III LLC | 5.71M | 42.90% | 5.71M | — | 5.71M | — | OO | Delaware | 2016-05-13 | ↗ |
| 7 | Venture Partners LLC | 5.57M | 29.90% | 5.57M | — | 5.57M | — | OO | Delaware | 2018-04-26 | ↗ |
| 8 | Partners III LLC | 2.82M | 13.90% | 2.82M | — | 2.82M | — | OO | Delaware | 2018-04-26 | ↗ |
| 9 | Pavilion Venture Partners LLC | 2.52M | 18.90% | 2.52M | — | 2.52M | — | OO | Delaware | 2016-05-13 | ↗ |
| 10 | Matthew Sirovich | 2.50M | 2.90% | 2.50M | — | 2.50M | — | IN | United States | 2021-10-06 | ↗ |
| 11 | (1) BlackRock, Inc. | 1.44M | 1.60% | 1.44M | — | 1.44M | — | HC | Delaware | 2022-07-08 | ↗ |
| 12 | Sargent Investment Group, LLC | 1.01M | 5.80% | — | — | — | — | IA | MARYLAND | 2025-08-14 | ↗ |
| 13 | Tasso Partners, LLC | 913.0K | 14.30% | 913.0K | 913.0K | 913.0K | — | OO | DELAWARE | 2026-04-14 | ↗ |
| 14 | Capital LLC | 851.0K | 9.90% | 851.0K | — | 851.0K | — | IA | Delaware | 2024-02-14 | ↗ |
| 15 | Khatri | 851.0K | 9.90% | 851.0K | — | 851.0K | — | IN | Delaware | 2024-02-14 | ↗ |
| 16 | Opportunity Master Fund, SPC – Segregated Master Portfolio B | 851.0K | 9.90% | 851.0K | — | 851.0K | — | CO | Delaware | 2024-02-14 | ↗ |
| 17 | HCFP Inc. | 847.0K | 4.90% | 847.0K | — | 847.0K | — | CO | Delaware | 2018-02-28 | ↗ |
| 18 | Ayrton Capital LLC | 709.1K | 9.99% | — | — | — | — | IA | DELAWARE | 2026-05-11 | ↗ |
| 19 | Two Seas Capital LP | 657.2K | 9.99% | — | — | — | — | IA, PN | DELAWARE | 2026-05-15 | ↗ |
| 20 | FIRST MANHATTAN CO. LLC. | 639.2K | 9.60% | 471.00 | 471.00 | 471.00 | — | IA | DELAWARE | 2026-05-14 | ↗ |
| 21 | Scopia Holdings LLC | 630.1K | 9.90% | — | — | — | — | PN | DELAWARE | 2026-04-13 | ↗ |
| 22 | Dubreville | 606.3K | 5.50% | 606.3K | — | 606.3K | — | IN | United States | 2024-09-23 | ↗ |
| 23 | Family Trust | 556.8K | 5.00% | 556.8K | — | 556.8K | — | OO | United States | 2024-09-23 | ↗ |
| 24 | NAGELBERG DAVID S | 547.0K | 8.60% | — | — | — | — | IN | UNITED STATES | 2026-04-08 | ↗ |
| 25 | Kallman Craig | 384.6K | 6.00% | — | — | — | — | IN | UNITED STATES | 2026-04-03 | ↗ |
| 26 | Aklog Lishan | 369.1K | 5.10% | 369.0K | 45.00 | 369.0K | 45.00 | IN | UNITED STATES | 2026-04-09 | ↗ |
| 27 | Dols Scott V. | 346.2K | 5.40% | — | — | — | — | IN | UNITED STATES | 2026-04-08 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2025 Q4
Investors holding
27
-6 vs prev Q
New positions
4
Closed positions
10
Increased
11
Reduced
5
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | FIRST MANHATTAN CO. LLC. | 714.1K +— (+0.0%) | 157.7K -150.1K (-48.8%) | 3.31% +3.309 pp | 0.00% 0.000 pp | USD2.15 +207.9% | 9 qtrs — |
| 2 | VANGUARD GROUP INC | 342.2K +133.8K (+64.2%) | 75.6K -14.6K (-16.2%) | 1.59% +1.586 pp | 0.00% +0.000 pp | USD1.87 +254.0% | 9 qtrs — |
| 3 | UBS GROUP AG | 219.8K +218.9K (+25,194.9%) | 48.6K +48.2K (+12,854.4%) | 1.02% +1.020 pp | 0.00% +0.000 pp | USD5.91 +12.0% | 9 qtrs — |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 168.8K +72.3K (+74.8%) | 39.8K -2.0K (-4.7%) | 0.78% +0.783 pp | 0.00% +0.000 pp | USD2.64 +150.8% | 9 qtrs — |
| 5 | NORTHERN TRUST CORP | 107.3K +60.8K (+130.8%) | 23.7K +3.7K (+18.2%) | 0.50% +0.498 pp | 0.00% +0.000 pp | USD1.36 +386.8% | 9 qtrs — |
| 6 | BLACKROCK, INC. | 72.4K -235.0 (-0.3%) | 16.0K -15.3K (-48.9%) | 0.34% +0.336 pp | 0.00% +0.000 pp | USD1.23 +438.2% | 6 qtrs — |
| 7 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 68.2K +68.2K (+100.0%) | 15.1K +15.1K (+100.0%) | 0.32% +0.317 pp | 0.00% +0.000 pp | USD6.62 +0.0% | 1 qtrs NEW |
| 8 | GSA CAPITAL PARTNERS LLP | 65.9K +65.9K (+100.0%) | 15.0K +15.0K (+100.0%) | 0.31% +0.306 pp | 0.00% +0.001 pp | USD6.62 +0.0% | 1 qtrs NEW |
| 9 | LPL FINANCIAL LLC | 55.6K +33.0 (+0.1%) | 12.3K -11.7K (-48.7%) | 0.26% +0.258 pp | 0.00% +0.000 pp | USD0.72 +819.4% | 4 qtrs — |
| 10 | XTX TOPCO LTD | 41.7K +29.4K (+239.1%) | 9.2K +3.9K (+72.9%) | 0.19% +0.194 pp | 0.00% +0.000 pp | USD0.43 +1,439.5% | 4 qtrs — |
| 11 | STATE STREET CORP | 20.9K +— (+0.0%) | 4.6K -4.4K (-49.0%) | 0.10% +0.097 pp | 0.00% +0.000 pp | USD4.12 +60.7% | 9 qtrs — |
| 12 | STONEX GROUP INC. | 12.3K +12.3K (+100.0%) | 2.7K +2.7K (+100.0%) | 0.06% +0.057 pp | 0.00% +0.000 pp | USD6.62 +0.0% | 1 qtrs NEW |
| 13 | XML FINANCIAL, LLC | 10.1K +— (+0.0%) | 2.2K -2.1K (-48.8%) | 0.05% -0.009 pp | 0.00% 0.000 pp | USD4.12 +60.7% | 9 qtrs — |
| 14 | MORGAN STANLEY | 4.8K -200.0 (-4.0%) | 1.1K -1.1K (-50.8%) | 0.02% +0.022 pp | 0.00% +0.000 pp | USD2.97 +122.9% | 9 qtrs — |
| 15 | CWM, LLC | 4.7K -1.7K (-27.1%) | 1.0K -2.0K (-66.7%) | 0.02% -0.014 pp | 0.00% +0.000 pp | USD3.16 +109.5% | 9 qtrs — |
| 16 | TOWER RESEARCH CAPITAL LLC (TRC) | 4.4K -18.0 (-0.4%) | 964.00 -926.0 (-49.0%) | 0.02% +0.020 pp | 0.00% +0.000 pp | USD1.44 +359.7% | 9 qtrs — |
| 17 | WELLS FARGO & COMPANY/MN | 1.6K +— (+0.0%) | 363.00 -346.0 (-48.8%) | 0.01% +0.008 pp | 0.00% +0.000 pp | USD3.67 +80.4% | 9 qtrs — |
| 18 | SIMPLEX TRADING, LLC | 1.0K +1.0K (+100.0%) | 231.00 +231.0 (+100.0%) | 0.00% +0.005 pp | 0.00% +0.000 pp | USD6.61 +0.2% | 1 qtrs NEW |
| 19 | CIBC PRIVATE WEALTH GROUP, LLC | 836.00 +— (+0.0%) | 185.00 -175.0 (-48.6%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD2.01 +229.4% | 8 qtrs — |
| 20 | JONES FINANCIAL COMPANIES LLLP | 246.00 +— (+0.0%) | 54.00 -50.0 (-48.1%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.61 +985.2% | 5 qtrs — |
| 21 | BANK OF AMERICA CORP /DE/ | 216.00 +85.0 (+64.9%) | 48.00 -8.0 (-14.3%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD0.83 +697.6% | 9 qtrs — |
| 22 | ALLWORTH FINANCIAL LP | 161.00 -134.0 (-45.4%) | 36.00 -92.0 (-71.9%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD3.91 +69.3% | 9 qtrs — |
| 23 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 95.00 +— (+0.0%) | 20.00 -21.0 (-51.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.63 +950.8% | 4 qtrs — |
| 24 | ADVISOR GROUP HOLDINGS, INC. | 81.00 +— (+0.0%) | 16.00 -19.0 (-54.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.70 +78.9% | 9 qtrs — |
| 25 | BNP PARIBAS ARBITRAGE, SNC | 30.00 +— (+0.0%) | 7.00 -6.0 (-46.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 3 qtrs — |
| 26 | JPMORGAN CHASE & CO | 18.00 +— (+0.0%) | 4.00 -4.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.33 +98.8% | 9 qtrs — |
| 27 | GROUP ONE TRADING, L.P. | 12.00 +— (+0.0%) | 3.00 -2.0 (-40.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 5 qtrs — |
| 28 | JANE STREET GROUP, LLC | — -152.3K (-100.0%) | — -65.6K (-100.0%) | 0.00% -0.842 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 29 | CITIGROUP INC | — -38.0 (-100.0%) | — -16.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 30 | CAPTRUST FINANCIAL ADVISORS | — -65.0K (-100.0%) | — -28.0K (-100.0%) | 0.00% 0.000 pp | 0.00% 0.000 pp | USD— | 4 qtrs SOLD |
| 31 | VIRTU FINANCIAL LLC | — -39.0K (-100.0%) | — -17.0K (-100.0%) | 0.00% 0.000 pp | 0.00% -0.001 pp | USD— | 4 qtrs SOLD |
| 32 | BARCLAYS PLC | — -69.0 (-100.0%) | — -29.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 33 | SBI SECURITIES CO., LTD. | — -109.0 (-100.0%) | — -47.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 34 | ADVISORNET FINANCIAL, INC | — -5.0 (-100.0%) | — -2.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 35 | OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | — -21.5K (-100.0%) | — -9.3K (-100.0%) | 0.00% -0.119 pp | 0.00% 0.000 pp | USD— | 6 qtrs SOLD |
| 36 | SUMMIT WEALTH GROUP LLC / CO | — -43.0K (-100.0%) | — -2.3M (-100.0%) | 0.00% 0.000 pp | 0.00% -0.250 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.01% | 75.7K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 35.7K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
9
Sells
0
Shares acquired
819.7K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+819,650
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | White Debra | Director | A-Award | A | Common Stock | 13,930 | 0.00 | — | 21,097 | D | ↗ |
| 2026-04-02 | Sparks Ronald M | Director | A-Award | A | Common stock | 13,930 | 0.00 | — | 21,097 | D | ↗ |
| 2026-04-02 | O'Neil Shaun | Officer | A-Award | A | Common Stock | 110,000 | 0.00 | — | 115,598 | D | ↗ |
| 2026-04-02 | MCGRATH DENNIS M | Officer | A-Award | A | Common stock | 180,000 | 0.00 | — | 186,695 | D | ↗ |
| 2026-04-02 | Lee Victoria Tou-ho | Officer | A-Award | A | Common Stock | 70,000 | 0.00 | — | 71,666 | D | ↗ |
| 2026-04-02 | Gordon Michael Adam | Officer | A-Award | A | Common stock | 110,000 | 0.00 | — | 115,000 | D | ↗ |
| 2026-04-02 | Glennon Michael J | Director | A-Award | A | Common stock | 13,930 | 0.00 | — | 21,653 | D | ↗ |
| 2026-04-02 | Baxter Timothy E | Director | A-Award | A | Common stock | 13,930 | 0.00 | — | 21,097 | D | ↗ |
| 2026-04-02 | Aklog Lishan | Director / Officer | A-Award | A | Common Stock | 350,000 | 0.00 | — | 357,614 | D | ↗ |
| 2026-04-02 | Agrawal Sundeep | Director | A-Award | A | Common Stock | 13,930 | 0.00 | — | 19,337 | D | ↗ |
| 2026-03-27 | Tasso Partners, LLC | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 912,996 | D | ↗ |
| 2026-03-24 | Lee Victoria Tou-ho | Officer | — | — | Common Stock | 0 | 0.00 | — | 1,666 | D | ↗ |
| 2026-02-03 | Tasso Partners, LLC | 10% Owner | — | — | Warrants | 5,365 | 1,000.00 | 5.37M | 0 | D | ↗ |
| 2025-09-30 | White Debra | Director | A-Award | A | Common stock | 150,000 | 0.00 | — | 215,000 | D | ↗ |
| 2025-09-30 | Sparks Ronald M | Director | A-Award | A | Common stock | 150,000 | 0.00 | — | 215,000 | D | ↗ |
| 2025-09-30 | O'Neil Shaun | Officer | A-Award | A | Common Stock | 150,000 | 0.00 | — | 167,933 | D | ↗ |
| 2025-09-30 | MCGRATH DENNIS M | Officer | A-Award | A | Common Stock | 150,000 | 0.00 | — | 200,834 | D | ↗ |
| 2025-09-30 | Gordon Michael Adam | Officer | A-Award | A | Common Stock | 150,000 | 0.00 | — | 150,000 | D | ↗ |
| 2025-09-30 | Glennon Michael J | Director | A-Award | A | Common stock | 150,000 | 0.00 | — | 231,667 | D | ↗ |
| 2025-09-30 | Baxter Timothy E | Director | A-Award | A | Common stock | 150,000 | 0.00 | — | 215,000 | D | ↗ |
| 2025-09-30 | Aklog Lishan | Director / Officer | A-Award | A | Common Stock | 150,000 | 0.00 | — | 228,418 | D | ↗ |
| 2025-09-30 | Agrawal Sundeep | Director | A-Award | A | Common Stock | 150,000 | 0.00 | — | 162,195 | D | ↗ |
| 2025-02-21 | Tasso Partners, LLC | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 2,574,350 | D | ↗ |
| 2024-10-21 | Agrawal Sundeep | Director | A-Award | A | Employee stock option (right to buy) | 50,000 | 1.04 | 52.0K | 50,000 | D | ↗ |
| 2024-09-19 | Agrawal Sundeep | Director | A-Award | A | Employee stock option (right to buy) | 205,000 | 1.63 | 334.2K | 205,000 | D | ↗ |
| 2024-09-10 | Agrawal Sundeep | Director | — | — | Common stock | 0 | 0.00 | — | 12,195 | D | ↗ |
| 2024-02-22 | White Debra | Director | A-Award | A | Common stock | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2024-02-22 | Sparks Ronald M | Director | A-Award | A | Common stock | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2024-02-22 | Harvey Joan B | Director | A-Award | A | Common stock | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2024-02-22 | Glennon Michael J | Director | A-Award | A | Common stock | 65,000 | 0.00 | — | 315,000 | — | ↗ |
| 2024-02-22 | Cox James L | Director | A-Award | A | Common stock | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2024-02-22 | Baxter Timothy E | Director | A-Award | A | Common stock | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2023-01-30 | White Debra | Director | A-Award | A | Employee stock option (right to buy) | 450,000 | 0.48 | 216.0K | 450,000 | — | ↗ |
| 2023-01-30 | Sparks Ronald M | Director | A-Award | A | Employee stock option (right to buy) | 450,000 | 0.48 | 216.0K | 450,000 | — | ↗ |
| 2023-01-30 | Harvey Joan B | Director | A-Award | A | Employee stock option (right to buy) | 450,000 | 0.48 | 216.0K | 450,000 | — | ↗ |
| 2023-01-30 | Glennon Michael J | Director | A-Award | A | Employee stock option (right to buy) | 450,000 | 0.48 | 216.0K | 450,000 | — | ↗ |
| 2023-01-30 | Cox James L | Director | A-Award | A | Employee stock option (right to buy) | 450,000 | 0.48 | 216.0K | 450,000 | — | ↗ |
| 2023-01-30 | Baxter Timothy E | Director | A-Award | A | Employee stock option (right to buy) | 450,000 | 0.48 | 216.0K | 450,000 | — | ↗ |
| 2022-12-07 | Glennon Michael J | Director | P-Purchase | A | Common Stock | 100,000 | 0.62 | 62.3K | 250,000 | — | ↗ |
| 2022-12-06 | Glennon Michael J | Director | P-Purchase | A | Common Stock | 88,000 | 0.64 | 56.1K | 150,000 | — | ↗ |
| 2022-12-05 | Glennon Michael J | Director | P-Purchase | A | Common stock | 62,000 | 0.69 | 42.6K | 62,000 | — | ↗ |
| 2022-06-07 | Gordon Michael Adam | Officer | A-Award | A | Employee stock option (right to buy) | 400,000 | 0.00 | — | 400,000 | — | ↗ |
| 2022-05-31 | Gordon Michael Adam | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-05-04 | O'Neil Shaun | Officer | F-InKind | D | Common stock | 25,935 | 1.38 | 35.8K | 265,469 | — | ↗ |
| 2022-03-28 | MCGRATH DENNIS M | Officer | F-InKind | D | Common stock | 199,973 | 1.18 | 236.0K | 755,489 | — | ↗ |
| 2022-03-28 | Aklog Lishan | Officer | F-InKind | D | Common stock | 79,636 | 1.18 | 94.0K | 176,277 | — | ↗ |
| 2022-02-22 | O'Neil Shaun | Officer | — | D | Employee stock option (right to buy) | 100,000 | 1.00 | 100.0K | 0 | — | ↗ |
| 2022-02-18 | White Debra | Director | A-Award | A | Employee stock option (right to buy) | 80,000 | 1.59 | 127.2K | 80,000 | — | ↗ |
| 2022-02-18 | Sparks Ronald M | Director | A-Award | A | Employee stock option (right to buy) | 80,000 | 1.59 | 127.2K | 80,000 | — | ↗ |
| 2022-02-18 | MCGRATH DENNIS M | Officer | A-Award | A | Employee stock option (right to buy) | 150,000 | 1.59 | 238.5K | 150,000 | — | ↗ |
| 2022-02-18 | Glennon Michael J | Director | A-Award | A | Employee stock option (right to buy) | 80,000 | 1.59 | 127.2K | 80,000 | — | ↗ |
| 2022-02-18 | DeGuzman Brian J. | Officer | A-Award | A | Employee stock option (right to buy) | 50,000 | 1.59 | 79.5K | 50,000 | — | ↗ |
| 2022-02-18 | Cox James L | Director | A-Award | A | Employee stock option (right to buy) | 80,000 | 1.59 | 127.2K | 80,000 | — | ↗ |
| 2022-02-18 | Baxter Timothy E | Director | A-Award | A | Employee stock option (right to buy) | 80,000 | 1.59 | 127.2K | 80,000 | — | ↗ |
| 2022-02-18 | Aklog Lishan | Director / Officer / 10% Owner | A-Award | A | Employee stock option (right to buy) | 200,000 | 1.59 | 318.0K | 200,000 | — | ↗ |
| 2022-02-11 | Harvey Joan B | Director | A-Award | A | Employee stock option (right to buy) | 179,350 | 2.05 | 367.7K | 179,350 | — | ↗ |
| 2021-06-15 | Baxter Timothy E | Director | A-Award | A | Employee stock option (right to buy) | 75,000 | 5.79 | 434.3K | 75,000 | — | ↗ |
| 2021-06-10 | Baxter Timothy E | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-04-29 | White Debra | Director | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 4.81 | 481.0K | 100,000 | — | ↗ |
| 2021-04-22 | White Debra | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-04-01 | Weild IV David | Director | A-Award | A | Employee Stock Option (Right to Buy) | 50,000 | 4.44 | 222.0K | 50,000 | — | ↗ |
| 2021-04-01 | Sparks Ronald M | Director | A-Award | A | Employee Stock Option (Right to Buy) | 50,000 | 4.44 | 222.0K | 50,000 | — | ↗ |
| 2021-04-01 | MCGRATH DENNIS M | Officer | A-Award | A | Common Stock | 150,000 | 0.00 | — | 955,462 | — | ↗ |
| 2021-04-01 | Glennon Michael J | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 50,000 | 4.44 | 222.0K | 50,000 | — | ↗ |
| 2021-04-01 | DeGuzman Brian J. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 50,000 | 4.44 | 222.0K | 50,000 | — | ↗ |
| 2021-04-01 | Cox James L | Director | A-Award | A | Employee Stock Option (Right to Buy) | 50,000 | 4.44 | 222.0K | 50,000 | — | ↗ |
| 2021-04-01 | Battleman David S. | Director | A-Award | A | Employee Stock Option (Right to Buy) | 50,000 | 4.44 | 222.0K | 50,000 | — | ↗ |
| 2021-04-01 | Aklog Lishan | Director / Officer / 10% Owner | A-Award | A | Common Stock | 150,000 | 0.00 | — | 1,255,913 | — | ↗ |
| 2021-03-18 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 7,500 | 4.31 | 32.3K | 1,105,913 | — | ↗ |
| 2020-11-25 | SIROVICH MATTHEW | 10% Owner | S-Sale | D | Common Stock | 33,203 | 1.96 | 65.0K | 1,027,744 | — | ↗ |
| 2020-11-24 | SIROVICH MATTHEW | 10% Owner | S-Sale | D | Common Stock | 53,036 | 2.00 | 105.9K | 1,060,947 | — | ↗ |
| 2020-11-19 | SIROVICH MATTHEW | 10% Owner | S-Sale | D | Common Stock | 75,211 | 1.83 | 137.4K | 1,113,983 | — | ↗ |
| 2020-11-18 | SIROVICH MATTHEW | 10% Owner | S-Sale | D | Common Stock | 24,789 | 1.78 | 44.2K | 1,189,194 | — | ↗ |
| 2020-05-29 | SIROVICH MATTHEW | 10% Owner | S-Sale | D | Common Stock | 131,082 | 1.98 | 259.5K | 1,213,983 | — | ↗ |
| 2020-05-28 | SIROVICH MATTHEW | 10% Owner | S-Sale | D | Common Stock | 69,839 | 2.06 | 143.7K | 1,345,065 | — | ↗ |
| 2020-04-30 | Weild IV David | Director | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 2.19 | 219.0K | 100,000 | — | ↗ |
| 2020-04-30 | Sparks Ronald M | Director | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 2.19 | 219.0K | 100,000 | — | ↗ |
| 2020-04-30 | MCGRATH DENNIS M | Officer | A-Award | A | Common Stock | 250,000 | 0.00 | — | 791,704 | — | ↗ |
| 2020-04-30 | Glennon Michael J | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 2.19 | 219.0K | 100,000 | — | ↗ |
| 2020-04-30 | DeGuzman Brian J. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 50,000 | 2.19 | 109.5K | 50,000 | — | ↗ |
| 2020-04-30 | Cox James L | Director | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 2.19 | 219.0K | 100,000 | — | ↗ |
| 2020-04-30 | Battleman David S. | Director | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 2.19 | 219.0K | 100,000 | — | ↗ |
| 2020-04-30 | Aklog Lishan | Director / Officer / 10% Owner | A-Award | A | Common Stock | 250,000 | 0.00 | — | 1,098,413 | — | ↗ |
| 2020-01-30 | SIROVICH MATTHEW | 10% Owner | X-InTheMoney | A | Common Stock | 1,199,383 | 0.01 | 12.0K | 1,938,297 | — | ↗ |
| 2019-05-24 | MCGRATH DENNIS M | Officer | P-Purchase | A | Common Stock | 5,000 | 1.09 | 5.4K | 529,000 | — | ↗ |
| 2019-05-23 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 30,000 | 1.10 | 32.9K | 848,413 | — | ↗ |
| 2019-03-15 | MCGRATH DENNIS M | Officer | A-Award | A | Common Stock | 500,000 | 0.00 | — | 524,000 | — | ↗ |
| 2019-03-15 | Aklog Lishan | Director / Officer / 10% Owner | A-Award | A | Common Stock | 200,000 | 0.00 | — | 818,413 | — | ↗ |
| 2019-03-07 | Weild IV David | Director | A-Award | A | Employee Stock Option (Right to Buy) | 200,000 | 1.00 | 200.0K | 200,000 | — | ↗ |
| 2019-03-07 | Sparks Ronald M | Director | A-Award | A | Employee Stock Option (Right to Buy) | 200,000 | 1.00 | 200.0K | 200,000 | — | ↗ |
| 2019-03-07 | Glennon Michael J | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 200,000 | 1.00 | 200.0K | 200,000 | — | ↗ |
| 2019-03-07 | DeGuzman Brian J. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 1.00 | 100.0K | 100,000 | — | ↗ |
| 2019-03-07 | Cox James L | Director | A-Award | A | Employee Stock Option (Right to Buy) | 200,000 | 1.00 | 200.0K | 200,000 | — | ↗ |
| 2019-03-07 | Battleman David S. | Director | A-Award | A | Employee Stock Option (Right to Buy) | 200,000 | 1.00 | 200.0K | 200,000 | — | ↗ |
| 2018-12-27 | SIROVICH MATTHEW | 10% Owner | J-Other | A | Common Stock | 60,000 | 0.00 | — | 792,000 | — | ↗ |
| 2018-08-28 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 30,000 | 1.18 | 35.4K | 618,413 | — | ↗ |
| 2018-06-26 | Glennon Michael J | Director / Officer | J-Other | D | Series Z Warrants | 322,673 | 1.60 | 516.3K | 0 | — | ↗ |
| 2018-06-26 | DeGuzman Brian J. | Officer | J-Other | D | Series Z Warrants | 322,673 | 1.60 | 516.3K | 0 | — | ↗ |
| 2018-06-26 | Aklog Lishan | Director / Officer / 10% Owner | J-Other | A | Series Z Warrants | 968,019 | 1.60 | 1.55M | 2,078,285 | — | ↗ |
| 2018-06-12 | SIROVICH MATTHEW | 10% Owner | — | D | Series Z Warrants (right to buy) | 458,257 | 1.60 | 733.2K | 0 | — | ↗ |
| 2018-06-12 | MCGRATH DENNIS M | Officer | X-InTheMoney | D | Subscription Rights (Right to Buy) | 12,000 | 1.15 | 13.8K | 0 | — | ↗ |
| 2018-06-12 | Aklog Lishan | Director / Officer / 10% Owner | X-InTheMoney | A | Series Z Warrants | 980 | 1.60 | 1.6K | 980 | — | ↗ |
| 2018-06-08 | Greenspan Ira Scott | 10% Owner | S-Sale | D | Common Stock | 18,300 | 1.04 | 19.0K | 421,691 | — | ↗ |
| 2018-06-01 | Greenspan Ira Scott | 10% Owner | S-Sale | D | Common Stock | 532,255 | 0.97 | 516.3K | 439,991 | — | ↗ |
| 2018-04-20 | Aklog Lishan | Director / Officer / 10% Owner | G-Gift | D | Series Z Warrants | 12,450 | 1.60 | 19.9K | 363,313 | — | ↗ |
| 2018-04-05 | Aklog Lishan | Director / Officer / 10% Owner | D-Return | D | Warrants | 20,000 | 5.00 | 100.0K | 0 | — | ↗ |
| 2018-02-14 | Weild IV David | Director | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 2.01 | 201.0K | 100,000 | — | ↗ |
| 2018-02-14 | Sparks Ronald M | Director | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 2.01 | 201.0K | 100,000 | — | ↗ |
| 2018-02-14 | MCGRATH DENNIS M | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 195,108 | 2.01 | 392.2K | 195,108 | — | ↗ |
| 2018-02-14 | Glennon Michael J | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 2.01 | 201.0K | 100,000 | — | ↗ |
| 2018-02-14 | DeGuzman Brian J. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 2.01 | 201.0K | 100,000 | — | ↗ |
| 2018-02-14 | Cox James L | Director | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 2.01 | 201.0K | 100,000 | — | ↗ |
| 2018-02-14 | Battleman David S. | Director | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 2.01 | 201.0K | 100,000 | — | ↗ |
| 2018-02-14 | Aklog Lishan | Director / Officer / 10% Owner | A-Award | A | Employee Stock Option (Right to Buy) | 195,108 | 2.01 | 392.2K | 195,108 | — | ↗ |
| 2018-02-02 | Aklog Lishan | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 34,153 | 0.00 | — | 588,413 | — | ↗ |
| 2017-12-31 | Greenspan Ira Scott | Director / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 20,000 | — | ↗ |
| 2017-12-31 | Aklog Lishan | Director / Officer / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 20,000 | — | ↗ |
| 2017-12-21 | Lamstein Joshua R | Director | J-Other | A | Common Stock | 79,560 | 0.00 | — | 163,177 | — | ↗ |
| 2017-12-21 | Glennon Michael J | Director / Officer | J-Other | A | Common Stock | 645,346 | 0.00 | — | 645,346 | — | ↗ |
| 2017-12-21 | DeGuzman Brian J. | Officer | J-Other | D | Common Stock | 645,346 | 0.00 | — | 0 | — | ↗ |
| 2017-11-22 | Greenspan Ira Scott | Director / 10% Owner | J-Other | D | Common Stock | 67,317 | 0.00 | — | 5,646,562 | — | ↗ |
| 2017-11-22 | Aklog Lishan | Director / Officer / 10% Owner | J-Other | D | Warrants | 67,317 | 5.00 | 336.6K | 5,646,562 | — | ↗ |
| 2017-11-21 | Aklog Lishan | Director / Officer / 10% Owner | L-Small | A | Common Stock | 1,200 | 4.30 | 5.2K | 71,489 | — | ↗ |
| 2017-11-20 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 950 | 4.70 | 4.5K | 70,289 | — | ↗ |
| 2017-11-17 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 601 | 4.37 | 2.6K | 69,339 | — | ↗ |
| 2017-09-15 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,600 | 8.77 | 22.8K | 68,738 | — | ↗ |
| 2017-09-13 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 100 | 5.00 | 500.00 | 50,400 | — | ↗ |
| 2017-09-12 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 200 | 5.00 | 1.0K | 50,300 | — | ↗ |
| 2017-09-11 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 300 | 6.38 | 1.9K | 65,738 | — | ↗ |
| 2017-09-08 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 300 | 5.00 | 1.5K | 50,100 | — | ↗ |
| 2017-09-07 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 850 | 5.11 | 4.3K | 65,038 | — | ↗ |
| 2017-09-06 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 899 | 4.85 | 4.4K | 64,188 | — | ↗ |
| 2017-09-05 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 800 | 4.74 | 3.8K | 63,289 | — | ↗ |
| 2017-09-01 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 300 | 4.46 | 1.3K | 62,489 | — | ↗ |
| 2017-08-31 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,600 | 4.27 | 6.8K | 62,189 | — | ↗ |
| 2017-08-30 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 200 | 5.00 | 1.0K | 46,700 | — | ↗ |
| 2017-08-29 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 1,200 | 5.00 | 6.0K | 46,500 | — | ↗ |
| 2017-08-25 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 900 | 4.21 | 3.8K | 58,877 | — | ↗ |
| 2017-08-24 | MCGRATH DENNIS M | Officer | P-Purchase | A | Common Stock | 500 | 4.24 | 2.1K | 10,500 | — | ↗ |
| 2017-08-24 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,200 | 4.23 | 5.1K | 57,977 | — | ↗ |
| 2017-08-23 | MCGRATH DENNIS M | Officer | P-Purchase | A | Common Stock | 500 | 4.18 | 2.1K | 9,000 | — | ↗ |
| 2017-08-23 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 7,900 | 4.21 | 33.3K | 56,777 | — | ↗ |
| 2017-08-22 | MCGRATH DENNIS M | Officer | P-Purchase | A | Common Stock | 500 | 4.12 | 2.1K | 3,500 | — | ↗ |
| 2017-08-22 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,500 | 4.18 | 6.3K | 48,877 | — | ↗ |
| 2017-08-21 | MCGRATH DENNIS M | Officer | P-Purchase | A | Common Stock | 500 | 4.09 | 2.0K | 500 | — | ↗ |
| 2017-08-21 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 7,500 | 4.20 | 31.5K | 47,377 | — | ↗ |
| 2017-08-18 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 100 | 5.00 | 500.00 | 44,700 | — | ↗ |
| 2017-08-17 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,800 | 3.43 | 6.2K | 31 | — | ↗ |
| 2017-08-16 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 3.35 | 335.00 | 300 | — | ↗ |
| 2017-08-03 | Battleman David S. | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 2.98 | 119.2K | 40,000 | — | ↗ |
| 2017-03-20 | MCGRATH DENNIS M | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 250,000 | 5.95 | 1.49M | 250,000 | — | ↗ |
| 2017-01-11 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 25,000 | 5.00 | 125.0K | 44,500 | — | ↗ |
| 2016-12-31 | Greenspan Ira Scott | Director / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 125,000 | — | ↗ |
| 2016-12-09 | Greenspan Ira Scott | Director / 10% Owner | L-Small | A | Warrants | 320 | 5.00 | 1.6K | 28,293 | — | ↗ |
| 2016-11-29 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,777 | 9.02 | 16.0K | 28,377 | — | ↗ |
| 2016-11-28 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 9.53 | 9.5K | 26,600 | — | ↗ |
| 2016-11-23 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,200 | 8.98 | 19.8K | 25,600 | — | ↗ |
| 2016-11-22 | Lamstein Joshua R | Director | P-Purchase | A | Warrants | 100 | 5.00 | 500.00 | 100 | — | ↗ |
| 2016-11-21 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 900 | 9.93 | 8.9K | 23,400 | — | ↗ |
| 2016-11-18 | Lamstein Joshua R | Director | P-Purchase | A | Common Stock | 100 | 10.38 | 1.0K | 100 | — | ↗ |
| 2016-11-18 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,400 | 10.07 | 14.1K | 22,500 | — | ↗ |
| 2016-09-16 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 200 | 13.98 | 2.8K | 20,700 | — | ↗ |
| 2016-09-15 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 300 | 13.95 | 4.2K | 20,100 | — | ↗ |
| 2016-09-14 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 200 | 14.45 | 2.9K | 19,800 | — | ↗ |
| 2016-09-13 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 500 | 5.00 | 2.5K | 18,650 | — | ↗ |
| 2016-09-01 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 200 | 13.98 | 2.8K | 18,800 | — | ↗ |
| 2016-08-26 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 400 | 14.30 | 5.7K | 18,300 | — | ↗ |
| 2016-08-25 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 200 | 5.00 | 1.0K | 17,850 | — | ↗ |
| 2016-08-24 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 500 | 14.23 | 7.1K | 17,900 | — | ↗ |
| 2016-08-23 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 100 | 5.00 | 500.00 | 19,250 | — | ↗ |
| 2016-06-01 | Fitzgerald Richard F | Officer | P-Purchase | A | Common Stock | 200 | 11.10 | 2.2K | 200 | — | ↗ |
| 2016-05-31 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 900 | 5.00 | 4.5K | 16,400 | — | ↗ |
| 2016-05-27 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 1,500 | 5.00 | 7.5K | 15,500 | — | ↗ |
| 2016-05-26 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,500 | 5.00 | 7.5K | 14,000 | — | ↗ |
| 2016-05-25 | Fitzgerald Richard F | Officer | P-Purchase | A | Common Stock | 100 | 9.75 | 975.00 | 100 | — | ↗ |
| 2016-05-25 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 2,500 | 5.00 | 12.5K | 12,500 | — | ↗ |
| 2016-05-24 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,000 | 5.00 | 10.0K | 10,000 | — | ↗ |
| 2016-05-23 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 2,900 | 5.00 | 14.5K | 8,000 | — | ↗ |
| 2016-05-20 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,700 | 5.00 | 8.5K | 5,100 | — | ↗ |
| 2016-05-19 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 1,400 | 5.00 | 7.0K | 3,400 | — | ↗ |
| 2016-05-18 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 1,500 | 5.00 | 7.5K | 2,000 | — | ↗ |
| 2016-05-17 | Aklog Lishan | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 400 | 9.50 | 3.8K | 500 | — | ↗ |
| 2016-04-28 | Weild IV David | Director | A-Award | A | Employee Stock Option (Right to Buy) | 97,554 | 5.00 | 487.8K | 97,554 | — | ↗ |
| 2016-04-28 | Sparks Ronald M | Director | A-Award | A | Employee Stock Option (Right to Buy) | 97,554 | 5.00 | 487.8K | 97,554 | — | ↗ |
| 2016-04-28 | Lamstein Joshua R | Director | A-Award | A | Employee Stock Option (Right to Buy) | 97,554 | 5.00 | 487.8K | 97,554 | — | ↗ |
| 2016-04-28 | Greenspan Ira Scott | Director / 10% Owner | A-Award | A | Common Stock | 20,000 | 5.00 | 100.0K | 20,000 | — | ↗ |
| 2016-04-28 | Glennon Michael J | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 278,726 | 5.00 | 1.39M | 278,726 | — | ↗ |
| 2016-04-28 | Fitzgerald Richard F | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 125,000 | 5.00 | 625.0K | 125,000 | — | ↗ |
| 2016-04-28 | DeGuzman Brian J. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 278,726 | 5.00 | 1.39M | 278,726 | — | ↗ |
| 2016-04-28 | Cox James L | Director | A-Award | A | Employee Stock Option (Right to Buy) | 97,554 | 5.00 | 487.8K | 97,554 | — | ↗ |
| 2016-04-28 | Aklog Lishan | Director / Officer / 10% Owner | A-Award | A | Employee Stock Option (Right to Buy) | 278,726 | 5.00 | 1.39M | 278,726 | — | ↗ |
| 2016-01-29 | Weild IV David | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-01-29 | Sparks Ronald M | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-01-29 | Lamstein Joshua R | Director | — | D | Warrant | 83,617 | 5.00 | 418.1K | 0 | — | ↗ |
| 2016-01-29 | Greenspan Ira Scott | Director | — | D | Warrant | 27,837 | 5.00 | 139.2K | 0 | — | ↗ |
| 2016-01-29 | Glennon Michael J | Director / Officer / 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-01-29 | Fitzgerald Richard F | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-01-29 | DeGuzman Brian J. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-01-29 | Cox James L | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-01-29 | Aklog Lishan | Director / Officer / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 5,713,879 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-628.00
Shares Outstanding
537.0K
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Lishan Aklog | Chairman & Chief Executive Officer | 970.2K | — |
| Dennis McGrath | President & Chief Financial Officer | 602.4K | male |
| Michael Adam Gordon | Executive Vice President, General Counsel & Secretary | 573.6K | male |
| Brian J. deGuzman | Executive Vice President, Chief Technology & Compliance Officer | 427.6K | — |
| Shaun O'Neil | Executive Vice President & Chief Operating Officer | 417.4K | male |
| Victoria T. Lee | Executive Vice President & Chief Medical Officer | — | — |
| Deepika A. Lakhani | Senior Vice President, Chief Regulatory & Quality Officer | — | — |
| Joseph Virgilio | SVP & Chief Business Officer of Medical Devices | — | male |
| Matthew Riley | Senior Director of Investor Relations | — | male |
| Suman Verma | Senior Vice President of Molecular Genetics & Chief Scientific Officer | — | — |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PAVM
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
